Related Experiment Video
Updated: May 8, 2026
A High-throughput, High-content, Liquid-based C. elegans Pathosystem
Published on: July 1, 2018
C. elegans for anti-infective discovery
Marios Arvanitis1, Justin Glavis-Bloom, Eleftherios Mylonakis
1Division of Infectious Diseases, Warren Alpert Medical School of Brown University, United States.
Abstract:
Widespread use of antimicrobial agents has led to the emergence of multidrug resistant pathogens, which are becoming increasingly common in clinical practice. This underscores the need to discover novel anti-infective compounds. The soil-living nematode Caenorhabditis elegans has proved to be an excellent model host in the search for such compounds. Indeed, this alternative host is successfully being used to identify traditional microbicidal agents, including antihelminthic compounds, as well as novel agents that attenuate microbial virulence or enhance the host's immune response. Thanks to numerous advantageous features, including its amenability to high-throughput automated screens that allow for the detection of bioactive products among thousands of tested substances, the C. elegans model is now in the spotlight of scientific attention.
Insights
The soil nematode Caenorhabditis elegans is a powerful model for discovering new antimicrobial compounds. Its use in high-throughput screening accelerates the identification of novel anti-infective agents to combat drug-resistant pathogens.
Area of Science:
- Microbiology
- Parasitology
- Drug Discovery
Background:
- Antimicrobial resistance (AMR) is a growing global health threat, necessitating novel anti-infective strategies.
- Traditional antimicrobial agents are facing challenges due to widespread resistance.
- There is an urgent need for innovative compounds to combat multidrug-resistant pathogens.
Purpose of the Study:
- To highlight the utility of Caenorhabditis elegans as a model organism for identifying novel anti-infective compounds.
- To showcase the potential of C. elegans in discovering agents that target microbial virulence and enhance host immunity.
- To emphasize the role of high-throughput screening in accelerating anti-infective drug discovery.
Main Methods:
- Utilizing Caenorhabditis elegans as a model host for screening potential anti-infective agents.
- Employing high-throughput automated screening assays to test large numbers of substances.
- Identifying compounds with microbicidal activity, virulence attenuation, or host immune-enhancement properties.
Main Results:
- Caenorhabditis elegans has proven effective in identifying both traditional and novel anti-infective compounds.
- The model system successfully detects agents that reduce microbial virulence.
- It also identifies compounds that bolster the host's immune defenses against pathogens.
Conclusions:
- The C. elegans model offers a robust platform for the discovery of novel anti-infective drugs.
- Its amenability to high-throughput screening makes it a valuable tool in the fight against antimicrobial resistance.
- Scientific attention is increasingly focused on C. elegans for its potential in developing next-generation anti-infectives.
